Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Jaron, Barbara ^a,b   Maranghi, Eddie ^a   Leclerc, Claude ^a,b   Majlessi, Laleh ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BASILIXIMAB; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; GROWTH REGULATION; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REGULATORY T LYMPHOCYTE; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; LUNG; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM; T LYMPHOCYTE;

CORYNEBACTERINEAE; MUS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 50949129546     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002833     Document Type: Article

References (47)

1. Cohen J (2006) Infectious disease. Extensively drug-resistant TB gets foothold in South Africa. Science 313: 1554.
2. WHO (2007) WHO report 2007. Global tuberculosis control.
3. Castillo-Rodal AI, Castanon-Arreola M, Hernandez-Pando R, Calva JJ, Sada-Diaz E, et al. (2006) Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Infect Immun 74: 1718-1724.
4. Fortin A, Abel L, Casanova JL, Gros P (2007) Host genetics of mice and men: Forward genetic studies of BCG-osis and tuberculosis. Annu Rev Genomics Hum Genet 8: 163-192.
5. Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, et al. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication or BCG and induction of protective immunity to tuberculosis. Infect Immun 70: 672-678.
6. Doherty TM (2005) Real world TB vaccines: clinical trials in TB-endemic regions. Vaccine 23: 2109-2114.
7. Gordon SV, Brosch R, Billault A, Garnier T, Eiglmeier K, et al. (1999) Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol 32: 643-655.
8. Brosch R, Gordon SV, Pym A, Eiglmeier K, Garnier T, et al. (2000) Comparative genomics of the mycobacteria. Int J Med Microbiol 290: 143-152.
9. Pymi AS, Brodin P, Brosch R, Huerre M, Cole ST (2002) Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46: 709-717.
10. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, et al. (2003) Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9: 533-539.
11. Majlessi L, Brodin P, Brosch R, Rojas MJ, Khun H, et al. (2005) Influence of ESAT-6 secretion system 1 (RD1) of Mycobacteriam tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol 174: 3570-3579.
12. Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13: 108-116.
13. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
14. Belkaid Y (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7: 875-888.
15. + regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol 84: 467-474.
16. Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, et al. (2007) Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobarterium tuberculosis. J Immunol 178: 2661-2665.
17. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, et al. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204: 2159-2169.
18. North RJ, Jung YJ (2004) Immunity to tuberculosis. Annu Rev Immunol 22: 599-623.
19. + T regulatory cells. J Immunol 176: 3301-3305.
20. + T regulatory cells". J Immunol 177: 2036; author reply 2037-2038.
21. + T regulatory cells". J Immunol 177: 2036-2037; author reply 2037-2038.
22. + regulatory T cells. Nat Med 10: 29-30.
23. Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, et al. (2005) Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 174: 4924-4933.
24. Fecci PE, Sweeney AE, Grossi PM, Nair SK, Learn CA, et al. (2006) Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin Cancer Res 12: 4294-4305.
25. Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R (2004) ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol 12: 500-508.
26. + T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. Infect Immun 74: 3396-3407.
27. Dietrich J, Aagaard C, Leah R, Olsen AW, Stzyhn A, et al. (2005) Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 174: 6332-6339.
28. Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, et al. (2005) Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol 175: 7264-7273.
29. + T cell responses. J Exp Med 196: 1585-1592.
30. +-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. Infect Immun 71: 7173-7177.
31. + T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med 200: 1479-1489.
32. Flynn JL (2006) Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 8: 1179-1188.
33. Lyadova IV, Eruslanov EB, Khaidukov SV, Yeremeev VV, Majorov KB, et al. (2000) Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease. J Immunol 165: 5921-5931.
34. Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197.
35. Hill JA, Benoist C, Mathis D (2007) Treg cells: guardians for life. Nat Immunol 8: 124-125.
36. + T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur J Immunol 38: 695-705.
37. Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, et al. (1999) Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162: 6740-6746.
38. Chen X, Oppenheim JJ, Howard OM (2005) BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25 - responder T cells than C57BL/6 mice. J Leukoc Biol 78: 114-121.
39. Lohr J, Knoechel B, Abbas AK (2006) Regulatory T cells in the periphery. Immunol Rev 212: 149-162.
40. Korn T, Benelli E, Gao W, Awasthi A, Jager A, et al. (2007) IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 148: 484-487.
41. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tubeculosis challenge. Nat Immunol 8: 369-377.
42. Umemura M, Yahagi A, Hamada S, Begum NM, Watanabe H, et al. (2007) IL-17-mediated regulation or innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178: 3786-3796.
43. Majlessi L, Combaluzier B, Albrecht I, Garcia JE, Nouze C, et al. (2007) Inhibition of phagosome maturation by mycobacteria does not interfere with presentation of mycobacterial antigens by MHC molecules. J Immunol 179: 1825-1833.
44. Huygen K, Lozes E, Gilles B, Drowart A, Palfliet K, et al. (1994) Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG. Infect Immun 62: 363-370.
45. Leclerc C, Deriaud E, Mimic V, van der Werf S (1991) Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J Virol 65: 711-718.
46. Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, et al. (2006) An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun 74: 2128-2137.
47. Preville X, Ladant D, Timmerman B, Leclerc C (2005) Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res 65: 641-649.